36C25622Q1492.pdf

PDF 924 KB Posted Sep 8, 2022

Attached to: 6505--RADIOPHARMACEUTICAL SUPPLIES
Solicitation number: 36C25622Q1492
Issued by: Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16

View the file

Other files

File	Type	Posted
36C25622Q1492_1.docx	DOCX document	Sep 8, 2022

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C25622Q1492 09-08-2022

Tammie Chaney 601-362-4471 ext. 56372 09-16-2022

1:00 pm CDT

00256

Department of Veterans Affairs

G.V. (Sonny) Montgomery VAMC

Network Contracting Office 16

715 South Pear Orchard Road

Ridgeland MS 39157

325412

1250 Employees

N/A

00586

Department of Veterans Affairs

G.V. (Sonny) Montgomery VAMC

A&MM Service (90C)

1500 E. Woodrow Wilson Drive

Jackson MS 39216-5199

10N16

Department of Veterans Affairs

G.V. (Sonny) Montgomery VAMC

A&MM Service (90C)

715 South Pear Orchard Road

Ridgeland MS 39157

FSC e-Invoice Payment http://www.fsc.va.gov/fsc/einvoice.asp

Invoice Setup Information 1-877-489-6135 invoice must be submitted electronically

1-877-489-6135

See CONTINUATION Page

See Price/Cost Schedule and Statement of Work

See CONTINUATION Page

586-3630160-048-822900-2580 010022900

X X

X 1

Tammie Chaney

36C25622Q1492

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

B.3 DELIVERY SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (NOV 2021)

C.2 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000) ...53

C.3 52.217-6 OPTION FOR INCREASED QUANTITY (MAR 1989)

C.4 52.217-7 OPTION FOR INCREASED QUANTITY—SEPARATELY PRICED LINE

ITEM (MAR 1989)

C.5 VAAR 852.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018)

C.6 VAAR 852.212-70 PROVISIONS AND CLAUSES APPLICABLE TO VA

ACQUISITION OF COMMERCIAL ITEMS (APR 2020)

C.7 VAAR 852.219-75 SUBCONTRACTING COMMITMENTS MONITORING AND

COMPLIANCE (JUL 2018)

C.8 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020)

C.9 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.10 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (MAY 2022) (JUL 2020) (DEVIATION)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (NOV 2021)

E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS

AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.3 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.4 52.216-1 TYPE OF CONTRACT (APR 1984)

E.5 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.6 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.7 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAY 2022) (JUL 2020)

(DEVIATION)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C256

Department of Veterans Affairs

G.V. (Sonny) Montgomery VAMC

Network Contracting Office 16

715 South Pear Orchard Road

Ridgeland MS 39157

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[X] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] Payment for services provided under the terms of this order will be made in arrears within thirty (30) days after completion of project and upon receipt of a properly executed invoice. Invoice(s) shall be submitted within ten (10) days after performance and acceptance of supplies.

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment

Requests.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

Statement of Work

Radiopharmaceuticals

1. General Description:

Radiopharmaceutical preparations of single unit patient doses, radiolabeled tagging of blood and testing performed at contractor facility, preparation of check sources for equipment Quality Control (QC), and delivery of ordered products to the Nuclear Medicine Department at the G.V. “Sonny” Montgomery VA Medical Center 1500 E.

Woodrow Wilson Drive Jackson, MS. 39216. Routine deliveries shall be made Monday through Friday from 6:30 am to 2:00 pm. Contractor shall provide emergency deliveries as requested by the VA Nuclear Medicine Departments.

Personnel assigned by the contractor to perform services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. Contractor shall secure FDA only approved radiopharmaceutical generators, kits, and any other products required to prepare radiopharmaceuticals. Contractor shall obtain such products only from suppliers licensed and inspected by the United States Nuclear Regulatory Commission or an Agreement State to provide such goods and services.

2. Clinical Duties:

Contractor’s employees shall give deliveries directly to the Nuclear Medicine Technologist on duty except in cases of after-hours deliveries. For after-hours deliveries including deliveries made prior to VA Nuclear Medicine Department opening, the contractor shall report to the Police Services dispatch office to verify identification and sign for the key accessing the nuclear medicine hot lab. The delivery shall be left locked inside the nuclear medicine hot lab for use later by the Nuclear Medicine Technologist. Upon completing the delivery, the Contractor’s delivery person shall return to the Police Services dispatch office to log out and return the key accessing the nuclear medicine hot lab. Delivery personnel shall be bonded by the contractor. Contractor must be able to deliver within 1 hour of receipt of a request for those radioactive isotopes listed in the Schedule which have limited half-life.

3. Administration:

a. Contractor shall bill on a monthly basis.

b. All services rendered shall be itemized by date of service, radiopharmaceutical provided, and unit cost.

4. Ordering Procedures:

Delivery Orders will be issued by the Contracting Officer and orders will be placed by Contracting Officer Representative (COR), or designee, as needed. Orders normally will be placed by 5 p.m. delivery shall be required by 6:30 am the following work day.

The delivery order shall specify contract item (s), quantity, performance period and applicable VA order number.

Orders can be placed orally by telephone, computer, and/or fax transmission.

5. Inspection/Acceptance (Inspection and Acceptance will take place at address listed in Section 7 b):

a. Any dose that is below standard in that it results in a non-diagnostic study that causes the patient having to repeat the study, causing delay in care and receiving unnecessary radiation exposure shall not exceed one per quarter, i.e. 4 per year. The VA will not be financially liable for unacceptable dosages.

b. All packaging and labelling shall meet all local, state, and Federal regulations for radioactive material. All packaging of radioactive material shall be clearly labelled “RADIOACTIVE” on the outside of packaging. All products shall be labelled with the name of the radiopharmaceutical, time of preparation, expiration time and date.

c. Incorrectly delivered doses shall not exceed one per quarter.

d. It is the offeror’s responsibility to provide the VA with recall notices on any product that has been delivered to the VA that may be defective. Notification shall be made to the Contracting Officer Representative via the most expedient method.

6. Additional Requirement: Radiopharmaceuticals shall be prepared in accordance with state and federal regulations governing the receipt, handling, preparation and delivery of these isotopes for human use. Contractor shall provide verification of a valid radioactive material license issued by the MS State Department of Health/Division of Radiological Health or the U.S. Nuclear Regulatory Commission.

Proof of such licensure shall be considered as verification that the Contractor has approved distribution procedures in place to ensure security of radioisotopes during receipt, preparation and delivery, as well as required training for delivery personnel and any others that may come in contact with radiopharmaceuticals. Contractor shall provide verification of licensure of all radio pharmacists preparing radiopharmaceuticals. Contractor shall provide its Quality Management Program (QMP). This program shall include, but not be limited to (1) the Contractors procedure for the preparation of radiopharmaceuticals (2) where preparation of radiopharmaceuticals is carried out (3) Quality Control (QC) guidelines the Contractor follows for the dispensing of radiopharmaceuticals for human use (4) verification of the steps followed to test labeling efficiency of radiopharmaceutical kits and (4) the frequency of this testing. Contractor shall provide the protocol followed (such as Food & Drug Administration and or professional standards or guidelines) in determining expiration time or date on radiopharmaceutical doses.

Contractor shall provide steps followed to ensure purity and sterility during preparation of radiopharmaceuticals. In addition, Contractor shall state what procedures or guidelines are followed to ensure an aseptic environment. VA requires Contractor to provide guarantee of the quality and efficacy of labeled compounds (radiopharmaceuticals), in addition the Contractor shall declare the steps taken daily to ensure such efficacy. The QMP shall include the procedure used by the Contractor in the dispensing, packaging and delivery of radiopharmaceuticals. The names and addresses of all sources supplying radioisotopes to the Contractor shall be included, along with the names and addresses of all sources providing radiopharmaceutical kits to the Contractor.

7. Delivery Requirement:

a) Contractor shall provide daily deliveries as well as emergent deliveries.

Routine weekday (M-F) delivery times:

1st delivery 6:30 am (after hours)

All other deliveries between the hours of 7:00 am and 2:00 pm

Emergency orders shall be delivered within 60 minutes (1 hour) after receipt of order.

b) Delivery Location:

G.V. “Sonny” Montgomery VA Medical Center Nuclear Medicine Department (Basement) 1500 E. Woodrow Wilson Drive Jackson, MS. 39216

• Deliveries shall be made Monday-Friday (excluding holidays which are listed below) between the hours of 6:30 AM and 2:00 PM, except in the case of emergency.

Federal Holidays are as follows and include any other days specifically declared by the President of the United States to be deemed a holiday.

New Year’s Day Martin Luther King’s Birthday Presidents’ Day Memorial Day Independence Day Labor Day Columbus Day Veterans’ Day Thanksgiving Christmas

• Access to the Jackson VA Medical Center location during non-business hours shall be obtained by the Contractor’s delivery person presenting themselves at the Police Services dispatch office to verify identification and sign for the key accessing the nuclear medicine hot lab. Upon completing the delivery, the Contractor’s delivery person shall return to the Police Services dispatch office to log out and return the key accessing the nuclear medicine hot lab. It is not required by the U.S. Nuclear Regulatory Commission, VA policy, or the Joint Commission that VA Police officers accompany the Contractor’s delivery Person to the Nuclear Medicine department and supervise the delivery.

• Deliveries shall be supervised by the VA COR or their designee before beginning delivery operations by the VA COR contacting the Contractor to arrange for delivery supervision.

c) Work Hours:

Normal Work hours: Monday through Friday, 7:00 am - 4:30 pm.

After-hours: 4:30 pm – 7:00 am

d) Delivery Commitment:

As is general practice for nuclear pharmacies, the time of delivery shall be specified or mutually agreed to when the VA Nuclear Medicine Department places and order either by telephone or electronically by computer. This time of delivery shall become mandatory upon the Contractor. Commitment to specified deliver times is an industry standard practice. Failure to perform in accordance with the delivery commitment could result in patient care delays and rescheduled appointments. Therefore, failure to meet delivery time commitments may be grounds for termination of contract in accordance with the provisions for default.

8. Person Authorized to Place Orders:

In accordance with U.S. Nuclear Regulatory Commission regulations and the conditions of the facility Radioactive Material Permit issued by the VHA National Health Physics Program, a certified Nuclear Medicine Technologist working under the supervision of an Authorized User physician approved by the facility Radiation Safety Committee is the only Jackson VA Medical Center representative who may order radiopharmaceuticals provided under this contact.

9. The services specified herein may be changed by written modification. The modification will be prepared by the VA Contracting Officer prior to becoming effective, shall be approved by the VA Undersecretary for Health or his/her designee.

10. Changes to Statement of Work:

The Contracting Officer is the only person authorized to approve changes or modify any of the requirements under this contract and such changes will be executed bi-laterally in accordance with FAR 52.212-4(c). The Contractor shall communicate with the Contracting Officer on all matters pertaining to contract administration.

Only the Contracting Officer is authorized to make commitments or issue changes, which will affect price, quantity, or quality of performance of this contract. In the event the contractor effects any such change at the direction of any person other than the Contracting Officer, the change shall be considered to have been made without authority and no adjustment will be made in the contract price to cover any increase in costs incurred as a result thereof.

11. Participate in a Post-Award Conference:

This meeting shall provide an introduction between the Contractor personnel and Government personnel who will be involved with the contract. The meeting shall provide the opportunity to discuss technical, management and security issues. The Post Award Conference will aid both the Government and Contractor in achieving a clear and mutual understanding of all requirements and identify and resolve any potential issues. The Contractor shall be prepared to discuss any items requiring clarification and gather information as necessary to support each deliverable. The VA will provide the Contractor with a written summary of the Post-Award Conference.

12. VHA Supplemental Contract Requirements for Combatting COVID-19

1. Contractor employees who work in or travel to VHA locations must comply with the following:

a. Documentation requirements:

1) If fully vaccinated, shall show proof of vaccination.

i. NOTE: Acceptable proof of vaccination includes a signed record of immunization from a health care provider or pharmacy, a copy of the

COVID-19 Vaccination Record Card (CDC Form MLS-319813_r, published on September 3, 2020), or a copy of medical records documenting the vaccination.

2) If unvaccinated and granted a medical or religious exception, shall show negative COVID-19 test results dated within three calendar days prior to desired entry date. Test must be approved by the Food and Drug

Administration (FDA) for emergency use or full approval. This includes tests available by a doctor’s order or an FDA approved over-the-counter test.

3) Documentation cited in this section shall be digitally or physically maintained on each contractor employee while in a VA facility and is subject to inspection prior to entry to VA facilities and after entry for spot inspections by

Contracting Officer Representatives (CORs) or other hospital personnel.

4) Documentation will not be collected by the VA; contractors shall, at all times, adhere to and ensure compliance with federal laws designed to protect contractor employee health information and personally identifiable information.

2. Contractor employees are subject to daily screening for COVID-19 and may be denied entry to VA facilities if they fail to pass screening protocols. As part of the screening process contractors may be asked screening questions found on the COVID-19 Screening Tool. Check regularly for updates.

a. Contractor employees who work away from VA locations, but who will have direct contact with VA patients shall self-screen utilizing the COVID-19 Screening Tool, https://www.va.gov/covid19screen/ https://www.va.gov/covid19screen/ in advance, each day that they will have direct patient contact and in accordance with their person or persons who coordinate COVID-19 workplace safety efforts at covered contractor workplaces. Contractors shall, at all times, adhere to and ensure compliance with federal laws designed to protect contractor employee health information and personally identifiable information.

3. Contractor must immediately notify their COR or Contracting Officer if contract performance is jeopardized due to contractor employees being denied entry into VA Facilities.

4. For indefinite delivery contracts: Contractor agrees to comply with VHA

Supplemental Contract Requirements for any task or delivery orders issued prior to this modification when performance has already commenced.

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM

NUMBE

DESCRIPTION OF

SUPPLIES/SERVIC

QUANTIT

UNI

T UNIT PRICE AMOUNT

780.00 EA ________________

Tc-99m Calibration Source (up to 1mCi) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

125.00 EA ________________

Tc-99mUD Misc. (MUGA, GI Bleed, etc.)

Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

100.00 EA ________________

Tc-99m Choletec UD (Mebrofenin) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

500.00 EA ________________

Tc-99m HDP UD (Oxidronate) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

60.00 EA ________________

Tc-99m MAA UD Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAG-3 UD (Mertiatide) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m DTPA UD (ventilation imaging) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

50.00 EA ________________

Tc-99m Filtered Sulfur Colloid UD Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

2,000.00 EA ________________

Tc-99m Sestamibi UD Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

10.00 EA ________________

Gallium-67 UD per mCi (5mCi/dose) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

12.00 EA ________________

Thallium-201 UD per mCi (4mCi/dose) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

80.00 EA ________________

I-123 Sodium Iodide caps 200 uCi (2 caps/dose) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (up to 6mCi)

Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (ea. mCi over 6) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Octreotide (Pentetreotide) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

4.00 EA ________________

Sr-89 SrCl (Strontium) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Labeling Study 500uCi Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Ceretec WBC Labeling (exametazime) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023

PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

25.00 EA ________________

WBC Kit Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC pickup and disposal fee Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

30.00 EA ________________

Ventilation Scan Kit Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ultra Tag Kit Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide (Kinevac) vial Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Pyrophoshate (PYP) vial

Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

36.00 EA ________________

123 Iofluplane Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

99mtc Ceretric unit dose Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

2.00 EA ________________

I-123 Sodium Iodide caps 100 uCi Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 MIBG (Adreview) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

5.00 EA ________________

Indium 111-DTPA Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

8.00 EA ________________

Tc-99m Calibration Source (each mCi over 1) Contract Period: Base POP Begin: 10-01-2022 POP End: 09-30-2023 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (up to 1mCi) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

250.00 EA ________________

Tc-99mUD Misc. (MUGA, GI Bleed, etc.)

Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

200.00 EA ________________

Tc-99m Choletec UD (Mebrofenin) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

518.00 EA ________________

Tc-99m HDP UD (Oxidronate) Contract Period: Option 1 POP Begin: 10-01-2023

POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAA UD Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

140.00 EA ________________

Tc-99m MAG-3 UD (Mertiatide) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m DTPA UD (ventilation imaging) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Filtered Sulfur Colloid UD Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024

2,500.00 EA ________________

Tc-99m Sestamibi UD Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Gallium-67 UD per mCi (5mCi/dose) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Thallium-201 UD per mCi (4mCi/dose) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 200 uCi (2 caps/dose) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (up to 6mCi) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

140.00 EA ________________ ________________

I-131 Sodium Iodide caps (ea. mCi over 6)

Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Octreotide (Pentetreotide) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sr-89 SrCl (Strontium) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Labeling Study 500uCi Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Ceretec WBC Labeling (exametazime) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC Kit Contract Period: Option 1

POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC pickup and disposal fee Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ventilation Scan Kit Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ultra Tag Kit Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide (Kinevac) vial Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Pyrophoshate (PYP) vial Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024

123 Iofluplane Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

99mtc Ceretric unit dose Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 100 uCi Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 MIBG (Adreview) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Indium 111-DTPA Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (each mCi over 1) Contract Period: Option 1 POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (up to 1mCi) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99mUD Misc. (MUGA, GI Bleed, etc.)

Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Choletec UD (Mebrofenin) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m HDP UD (Oxidronate) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAA UD

Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAG-3 UD (Mertiatide) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m DTPA UD (ventilation imaging) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Filtered Sulfur Colloid UD Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sestamibi UD Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025

PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Gallium-67 UD per mCi (5mCi/dose) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Thallium-201 UD per mCi (4mCi/dose) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 200 uCi (2 caps/dose) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (up to 6mCi) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (ea. mCi over 6) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Octreotide (Pentetreotide)

Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sr-89 SrCl (Strontium) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Labeling Study 500uCi Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Ceretec WBC Labeling (exametazime) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC Kit Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC pickup and disposal fee Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ventilation Scan Kit Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ultra Tag Kit Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide (Kinevac) vial Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Pyrophoshate (PYP) vial Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

123 Iofluplane Contract Period: Option 2 POP Begin: 10-01-2024

POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

99mtc Ceretric unit dose Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 100 uCi Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 MIBG (Adreview) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Indium 111-DTPA Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (each mCi over 1) Contract Period: Option 2 POP Begin: 10-01-2024 POP End: 09-30-2025

Tc-99m Calibration Source (up to 1mCi) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99mUD Misc. (MUGA, GI Bleed, etc.)

Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Choletec UD (Mebrofenin) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m HDP UD (Oxidronate) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAA UD Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

140.00 EA ________________ ________________

Tc-99m MAG-3 UD (Mertiatide)

Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m DTPA UD (ventilation imaging) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Filtered Sulfur Colloid UD Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sestamibi UD Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Gallium-67 UD per mCi (5mCi/dose) Contract Period: Option 3

POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Thallium-201 UD per mCi (4mCi/dose) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 200 uCi (2 caps/dose) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (up to 6mCi) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (ea. mCi over 6) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Octreotide (Pentetreotide) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026

Sr-89 SrCl (Strontium) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Labeling Study 500uCi Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Ceretec WBC Labeling (exametazime) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC Kit Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC pickup and disposal fee Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ventilation Scan Kit Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ultra Tag Kit Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide (Kinevac) vial Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Pyrophoshate (PYP) vial Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

123 Iofluplane Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

99mtc Ceretric unit dose

Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 100 uCi Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 MIBG (Adreview) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Indium 111-DTPA Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (each mCi over 1) Contract Period: Option 3 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (up to 1mCi) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027

PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99mUD Misc. (MUGA, GI Bleed, etc.)

Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Choletec UD (Mebrofenin) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m HDP UD (Oxidronate) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAA UD Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m MAG-3 UD (Mertiatide) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m DTPA UD (ventilation imaging)

Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sulfur Colloid UD Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Filtered Sulfur Colloid UD Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Sestamibi UD Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Gallium-67 UD per mCi (5mCi/dose) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Thallium-201 UD per mCi (4mCi/dose) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 Sodium Iodide caps 200 uCi (2 caps/dose) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (up to 6mCi) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-131 Sodium Iodide caps (ea. mCi over 6) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 Octreotide (Pentetreotide) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sr-89 SrCl (Strontium) Contract Period: Option 4 POP Begin: 10-01-2026

POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

In-111 WBC Labeling Study 500uCi Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Ceretec WBC Labeling (exametazime) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC Kit Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

WBC pickup and disposal fee Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Ventilation Scan Kit Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027

Ultra Tag Kit Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Sincalide (Kinevac) vial Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Pyrophoshate (PYP) vial Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

123 Iofluplane Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

99mtc Ceretric unit dose Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

2.00 EA ________________ ________________

I-123 Sodium Iodide caps 100 uCi

Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

I-123 MIBG (Adreview) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Indium 111-DTPA Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

Tc-99m Calibration Source (each mCi over 1) Contract Period: Option 4 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical

GRAND TOTAL ________________

The guaranteed minimum contract amount, including the base period and any option periods exercised, is $100,000.00 and the maximum contract amount, including the base period and any option periods exercised, shall not exceed $3,500,000.00.

B.3 DELIVERY SCHEDULE

ITEM NUMBER QUANTITY

DELIVERY

DATE

780.00 10/01/2022- 09/30/2023

125.00 10/01/2022-

100.00 10/01/2022-

500.00 10/01/2022-

60.00 10/01/2022-

50.00 10/01/2022-

2,000.00 10/01/2022-

10.00 10/01/2022-

12.00 10/01/2022-

80.00 10/01/2022-

4.00 10/01/2022-

25.00 10/01/2022-

30.00 10/01/2022-

36.00 10/01/2022-

2.00 10/01/2022-

5.00 10/01/2022-

8.00 10/01/2022-

780.00 10/01/2023- 09/30/2024

250.00 10/01/2023-

200.00 10/01/2023-

518.00 10/01/2023-

100.00 10/01/2023-

140.00 10/01/2023-

125.00 10/01/2023-

2,500.00 10/01/2023-

250.00 10/01/2023-

12.00 10/01/2023-

4.00 10/01/2023-

25.00 10/01/2023-

30.00 10/01/2023-

36.00 10/01/2023-

2.00 10/01/2023-

5.00 10/01/2023-

8.00 10/01/2023-

780.00 10/01/2024- 09/30/2025

250.00 10/01/2024-

200.00 10/01/2024-

518.00 10/01/2024-

100.00 10/01/2024-

140.00 10/01/2024-

125.00 10/01/2024-

2,500.00 10/01/2024-

250.00 10/01/2024-

12.00 10/01/2024-

4.00 10/01/2024-

25.00 10/01/2024-

30.00 10/01/2024-

36.00 10/01/2024-

2.00 10/01/2024-

5.00 10/01/2024-

8.00 10/01/2024-

780.00 10/01/2025- 09/30/2026

250.00 10/01/2025-

200.00 10/01/2025-

518.00 10/01/2025-

100.00 10/01/2025-

140.00 10/01/2025-

125.00 10/01/2025-

2,500.00 10/01/2025-

250.00 10/01/2025-

12.00 10/01/2025-

4.00 10/01/2025-

25.00 10/01/2025-

30.00 10/01/2025-

36.00 10/01/2025-

2.00 10/01/2025-

5.00 10/01/2025-

8.00 10/01/2025-

780.00 10/01/2026- 09/30/2027

250.00 10/01/2026-

200.00 10/01/2026-

518.00 10/01/2026-

100.00 10/01/2026-

140.00 10/01/2026-

125.00 10/01/2026-

2,500.00 10/01/2026-

250.00 10/01/2026-

12.00 10/01/2026-

4.00 10/01/2026-

25.00 10/01/2026-

30.00 10/01/2026-

36.00 10/01/2026-

2.00 10/01/2026-

5.00 10/01/2026-

8.00 10/01/2026-

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (NOV 2021)

(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The

Government must exercise its post-acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered;

and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims

Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the

Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the

Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the

Contracting Officer of the cessation of such occurrence.

(g) Invoice.

(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—

(i) Name and address of the Contractor;

(ii) Invoice date and number;

(iii) Contract number, line item number and, if applicable, the order number;

(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;

(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;

(vi) Terms of any discount for prompt payment offered;

(vii) Name and address of official to whom payment is to be sent;

(viii) Name, title, and phone number of person to notify in event of defective invoice; and

(ix) Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required elsewhere in this contract.

(x) Electronic funds transfer (EFT) banking information.

(A) The Contractor shall include EFT banking information on the invoice only if required elsewhere in this contract.

(B) If EFT banking information is not required to be on the invoice, in order for the invoice to be a proper invoice, the Contractor shall have submitted correct EFT banking information in accordance with the applicable solicitation provision, contract clause (e.g., 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or 52.232-34, Payment by

Electronic Funds Transfer—Other Than System for Award Management), or applicable agency procedures.

(2) Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management and Budget (OMB) prompt payment regulations at 5 CFR part 1315.

(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.

(i) Payment.—

(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.

(2) Prompt payment. The Government will make…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated Sep 8, 2022.